LexaGene developed assays for detecting pathogens and whether they possess any drug resistant genes. Our market research indicates veterinarians and clinicians want technology to enable them to quickly determine the cause of a UTI and other types of infections, and whether antibiotic resistance genes are present, so they can prescribe the appropriate therapy upon the first visit to the veterinarian clinic.
Point-of-care diagnostics allows for a much better outcome over conventional culture and sensitivity testing. These tests required three-to-five days for results, during which time the animal’s condition might deteriorate.
Learn More About Antimicrobial Resistance
LexaGene’s veterinary diagnostic technology, MiQLab™, equips veterinarians to take better care of their patients by providing a correct diagnosis, faster, and minimizing unsuccessful treatment pathways.
Download our Antimicrobial Resistance in Veterinary Medicine Infographic to learn more… or contact sales@lexagene.com for a product demonstration.
